- Home
- LVLU vs NTRB Comparison
LVLU vs NTRB Comparison
Compare LVLU & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- NTRB
- Stock Information
- Founded
- LVLU 1996
- NTRB 2016
- Country
- LVLU United States
- NTRB United States
- Employees
- LVLU N/A
- NTRB N/A
- Industry
- LVLU Catalog/Specialty Distribution
- NTRB Industrial Specialties
- Sector
- LVLU Consumer Discretionary
- NTRB Health Care
- Exchange
- LVLU Nasdaq
- NTRB Nasdaq
- Market Cap
- LVLU 66.0M
- NTRB 77.9M
- IPO Year
- LVLU 2021
- NTRB N/A
- Fundamental
- Price
- LVLU $1.20
- NTRB $4.94
- Analyst Decision
- LVLU Hold
- NTRB
- Analyst Count
- LVLU 4
- NTRB 0
- Target Price
- LVLU $1.58
- NTRB N/A
- AVG Volume (30 Days)
- LVLU 37.3K
- NTRB 17.4K
- Earning Date
- LVLU 11-13-2024
- NTRB 12-11-2024
- Dividend Yield
- LVLU N/A
- NTRB N/A
- EPS Growth
- LVLU N/A
- NTRB N/A
- EPS
- LVLU N/A
- NTRB N/A
- Revenue
- LVLU $324,699,000.00
- NTRB $1,803,816.00
- Revenue This Year
- LVLU N/A
- NTRB N/A
- Revenue Next Year
- LVLU $3.39
- NTRB N/A
- P/E Ratio
- LVLU N/A
- NTRB N/A
- Revenue Growth
- LVLU N/A
- NTRB N/A
- 52 Week Low
- LVLU $1.02
- NTRB $2.22
- 52 Week High
- LVLU $2.84
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- LVLU 39.38
- NTRB 40.08
- Support Level
- LVLU $1.39
- NTRB $4.64
- Resistance Level
- LVLU $1.79
- NTRB $5.12
- Average True Range (ATR)
- LVLU 0.25
- NTRB 0.40
- MACD
- LVLU -0.04
- NTRB -0.04
- Stochastic Oscillator
- LVLU 2.90
- NTRB 23.48
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.